These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
423 related articles for article (PubMed ID: 7481864)
1. The platinum compounds and paclitaxel in the management of carcinomas of the endometrium and uterine cervix. Thigpen T; Vance RB; Khansur T Semin Oncol; 1995 Oct; 22(5 Suppl 12):67-75. PubMed ID: 7481864 [TBL] [Abstract][Full Text] [Related]
2. The role of paclitaxel in the management of patients with carcinoma of the cervix. Thigpen T; Vance R; Khansur T; Malamud F Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-41-S2-46. PubMed ID: 9045336 [TBL] [Abstract][Full Text] [Related]
3. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials. Thigpen T; Vance R; Puneky L; Khansur T Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816 [TBL] [Abstract][Full Text] [Related]
4. Medical therapy of advanced malignant epithelial tumours of the ovary. Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983 [TBL] [Abstract][Full Text] [Related]
5. The role of paclitaxel in the management of coelomic epithelial carcinoma of the ovary: a review with emphasis on the Gynecologic Oncology Group experience. Thigpen T; Vance RB; McGuire WP; Hoskins WJ; Brady M Semin Oncol; 1995 Dec; 22(6 Suppl 14):23-31. PubMed ID: 8553080 [TBL] [Abstract][Full Text] [Related]
6. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results. Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971 [TBL] [Abstract][Full Text] [Related]
7. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck. Shin DM; Glisson BS; Khuri FR; Ginsberg L; Lawhorn K; Hong WK; Lippman SM Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263 [TBL] [Abstract][Full Text] [Related]
8. Carboplatin plus paclitaxel as first-line chemotherapy in previously untreated advanced ovarian cancer. German AGO Study Group Ovarian Cancer. Arbeitsgemeinschaft Gynäkologische Onkologie. du Bois A; Lück HJ; Meier W; Möbus V; Costa S; Richter B; Bauknecht T; Warm M; Schroeder W; Olbricht S; Nitz U; Jackisch C Semin Oncol; 1997 Aug; 24(4 Suppl 11):S11-28-S11-33. PubMed ID: 9314296 [TBL] [Abstract][Full Text] [Related]
9. Clinical phase I study of paclitaxel followed by cisplatin in advanced head and neck squamous cell carcinoma. Hanauske AR; Schilling T; Heinrich B; Kau R; Herzog M; Quasthoff S; Bochtler H; Diergarten K; Rastetter J Semin Oncol; 1995 Dec; 22(6 Suppl 14):35-9. PubMed ID: 8553082 [TBL] [Abstract][Full Text] [Related]
10. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results. Belli L; LeChevalier T; Gottfried M; Adams D; Ruffie P; LeCesne A; Tete L; Pellae-Cosset B Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967 [TBL] [Abstract][Full Text] [Related]
11. Carboplatin versus cisplatin in ovarian cancer. Alberts DS Semin Oncol; 1995 Oct; 22(5 Suppl 12):88-90. PubMed ID: 7481869 [TBL] [Abstract][Full Text] [Related]
13. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Shin DM; Glisson BS; Khuri FR; Hong WK; Lippman SM Semin Oncol; 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061 [TBL] [Abstract][Full Text] [Related]
14. Maximum tolerated dose and early response - results of a phase I trial of paclitaxel and cisplatin with radiation therapy in carcinoma of the cervix. Prasad E; Viswanathan PN; Rangad VF; Pavamani S; Ram TS Clin Oncol (R Coll Radiol); 2009 Aug; 21(6):488-93. PubMed ID: 19386478 [TBL] [Abstract][Full Text] [Related]
15. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza. Zanetta G; Fei F; Mangioni C Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040 [TBL] [Abstract][Full Text] [Related]
16. Dose-escalated paclitaxel in 1-hour infusion with a fixed dose of cisplatin in previously untreated advanced ovarian cancer: a phase II trial of the Spanish Group for Ovarian Cancer. Cervantes A; Mendiola C; del Campo JM; Massuti B; Casado A; Escobedo A; Moyano A; Ojeda B; Poveda A; Benito D Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-40-S15-43. PubMed ID: 9346221 [TBL] [Abstract][Full Text] [Related]
17. Single-agent paclitaxel and paclitaxel plus ifosfamide in the treatment of head and neck cancer. Forastiere AA; Urba SG Semin Oncol; 1995 Jun; 22(3 Suppl 6):24-7. PubMed ID: 7597431 [TBL] [Abstract][Full Text] [Related]
18. The role of ifosfamide and systemic therapy in the management of carcinoma of the cervix. Thigpen T; Vance R; Khansur T; Malamud F Semin Oncol; 1996 Jun; 23(3 Suppl 6):56-64. PubMed ID: 8677451 [TBL] [Abstract][Full Text] [Related]
19. Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group). McGuire WP; Hoskins WJ; Brady MF; Kucera PR; Partridge EE; Look KY; Clarke-Pearson DL; Davidson M Semin Oncol; 1996 Oct; 23(5 Suppl 12):40-7. PubMed ID: 8941409 [TBL] [Abstract][Full Text] [Related]
20. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group. Mannel RS; Blessing JA; Boike G Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]